Early-stage startup founders offer heavily skewed, low-upside compensation packages to executive-level commercial hires while expecting them to build the entire revenue engine from scratch.
Early-stage startup founders offer heavily skewed, low-upside compensation packages to executive-level commercial hires while expecting them to build the entire revenue engine from scratch.
Not having equity at the level you're expected to be at is a huge red flag. Run.
commentNot having equity at the level you're expected to be at is a huge red flag. Run.
This comp package is insulting for what you’re being expected to deliver.
commentThis comp package is ~~borderline~~ insulting for what you’re being expected to deliver. You can argue that you’re delivering the hardest part. \^It honestly took me 8 minutes to write that. There are so many issues with this that I don’t even know where to start lol. I’d run for the hills personally.
The odds of a company hitting $3MM ARR he may as well be offering you a trip to Mars if you can hit that.
comment(Startup exec on the tech side, not a sales guy tho) So current ARR is <$50k? Sounds like it is a long way from product-market fit. Only about 4% of startups ever reach $1MM in ARR. The odds of a company hitting $3MM ARR he may as well be offering you a trip to Mars if you can hit that. Median ACV of under $3k is dismal for b2b SaaS, especially in a regulated industry (healthcare). $1MM in ARR will require adding 316 paying customers (so 500+ once you account for churn). Is the rest of the company set up to onboard and service that scale? You are a seasoned expert taking on a huge opportunity cost and deserve to be compensated for taking that risk. 1% equity cap and 5% commission for personally 20X'ing the company sounds like the upside for you would never equal the $300k you're giving up at your day job, let alone adjusting it for risk. Founder seems either exploitative or clueless. Neither bode well for you, or for the future of that company.
Incoming sales and commercial leaders assessing complex, high-risk compensation packages from early-stage startups.
Multiple commenters point out that 1% equity capped behind unrealistic revenue milestones is unfair and represents a widespread founder blind spot.
Purpose-built specifically for evaluating high-risk executive compensation and equity structures rather than general employee salary benchmarking.
A specialized benchmarking and negotiation advisory tool that helps commercial executives evaluate startup equity, base pay, and milestone-based commission structures against verified market standards.
Executives risking hundreds of thousands in opportunity cost will gladly pay a nominal fee to objectively vet multi-million dollar equity and commission structures.
“Evaluate startup executive compensation and equity risk in minutes.”
A specialized benchmarking and negotiation advisory tool that helps commercial executives evaluate startup equity, base pay, and milestone-based commission structures against verified market standards.
Target executive communities, professional networks on X, and career-focused subreddits (r/startups, r/sales).
Accurately benchmarking early-stage executive equity is difficult due to wide variance across seed-stage companies.
Users only evaluate executive offers during career transitions, leading to low lifetime retention.
Startups may resist standardized external benchmarks when negotiating customized deals.
Run an Investment Memo to get a structured Go / No-Go verdict, competitor landscape, unit economics, and a 90-day validation roadmap for this opportunity.
Generate an investment memoThis idea scores in the upper-middle range of opportunities surfaced by MonetScope, with a validation sub-score of 9/10 against 3 independently sourced evidence signals. A "promising" rating usually indicates a real pain has been detected and discussed in the open, but the pipeline did not find enough signal to flag it as urgent or high-frequency. These opportunities can still produce excellent businesses — they often correspond to "boring" problems that established players have ignored — but the founder should expect a longer customer-development cycle to confirm willingness to pay.
It sits at the intersection of "analytics", "hr", "productivity", which makes it relevant to a specific subset of founders rather than a generic horizontal opportunity. SaaS opportunities at this stage tend to win on the strength of their initial wedge — a single workflow that the target user runs every week, where the existing solution is either spreadsheets, a clunky incumbent feature, or a manual process they hate. The build cost is moderate; the distribution cost is everything. The MonetScope pipeline surfaces this category alongside other saas signals, which is why it appears here rather than in a generic "trending ideas" feed.
Scores are derived from real forum discussions across Reddit, Hacker News and X, weighted by evidence volume and signal quality. How scoring works
MonetScope does not generate ideas from a language model's imagination. Every opportunity on this site is anchored to specific source posts and comments from real public discussions — typically on Reddit, Hacker News, or X — where actual users describe the pain in their own words. The AI's role is structuring, scoring, and grouping those signals into a navigable opportunity, not inventing the problem.
MonetScope's spider pipeline runs continuously and surfaces opportunities as new evidence accumulates. The "Updated" date in the header reflects the most recent re-scoring of this specific opportunity. Most saas opportunities visible in the public catalog draw from discussions in the last 30-60 days; older signals are de-prioritized because user pain shifts faster than most founders assume.
Overall score is a composite across six dimensions — pain, urgency, willingness to pay, market size, defensibility, and execution ease — designed to give a single number for triage. Validation score is narrower: it asks "how cleanly does the same signal repeat across independent sources?" An opportunity can score high on overall but lower on validation when one or two large discussions dominate the evidence; conversely, validation can be high on a smaller-overall idea where the signal is consistent but the addressable market is modest.
